Given the lack of signals + no news flow + SPAC-like fundamentals (zero revenue), the risk/reward for an impatient buyer is unattractive at this moment.
Technical Analysis
Pre-market price ~10.51 is below S1 (10.539) and well below the Pivot (10.806), signaling a weak/defensive tape; next downside area is S2 (10.373).
MACD histogram (-0.0557) is below zero and expanding negatively → bearish momentum strengthening.
RSI_6 at ~21 suggests the stock is very stretched/oversold in the near term (bounce potential), but oversold alone is not a buy trigger without reversal confirmation.
Moving averages are converging → consolidation, but current momentum tilt remains bearish.
Near-term levels: Resistance at 10.806 (pivot) then 11.073 (R1); support at 10.539 (S1) then 10.373 (S2).
Positive Catalysts
can allow for a reflex bounce if buyers step in near 10.37–10.54 support.
Neutral/Negative Catalysts
No news in the past week → no event-driven catalyst to re-rate the stock.
Bearish momentum (MACD negative and worsening) with price trading below pivot/support levels.
Hedge funds and insiders show neutral activity → no visible accumulation signal.
SPAC-like profile with zero revenue reduces fundamental “buy now” conviction without a deal/catalyst.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 0 (flat YoY). This indicates no operating business revenue (typical of blank-check/SPAC structures).
Net income: 1,918,512 (flat YoY per data), likely driven by non-operating items (e.g., interest income) rather than business growth.
EPS: 0.06 (flat YoY per data).
Gross margin: 0 (flat YoY), consistent with no operating revenue.
Overall: financials do not show operating growth; they do not provide a strong fundamental reason to buy immediately.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target trend data provided.
Practical takeaway: without Street coverage/target changes, there’s no clear “pros vs cons” consensus catalyst to lean on; decision must rely on technicals and catalysts, both of which are currently weak.
Politicians/congress: No recent congress trading data available (last 90 days).
Wall Street analysts forecast CHAC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHAC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast CHAC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHAC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
